These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6376232)
41. [Insulin resistance and insulin secretion in type II non-obese diabetics]. Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572 [TBL] [Abstract][Full Text] [Related]
43. Relationship between oral glucose tolerance and insulin sensitivity in healthy man and type 1 diabetic patients. Yki-Järvinen H; Helve E; Koivisto VA Acta Endocrinol (Copenh); 1986 Jul; 112(3):355-60. PubMed ID: 3529781 [TBL] [Abstract][Full Text] [Related]
44. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy. Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679 [TBL] [Abstract][Full Text] [Related]
45. Reversal of insulin resistance in type 1 diabetes following initiation of insulin treatment. Gray RS; Cowan P; Duncan LJ; Clarke BF Diabet Med; 1986 Jan; 3(1):18-23. PubMed ID: 2951129 [TBL] [Abstract][Full Text] [Related]
46. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996 [TBL] [Abstract][Full Text] [Related]
47. Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man. Bratusch-Marrain PR; Vierhapper H; Komjati M; Waldhäusl WK Diabetologia; 1985 Sep; 28(9):671-6. PubMed ID: 3905478 [TBL] [Abstract][Full Text] [Related]
48. Normalization of plasma insulin profiles in diabetic subjects with programmed insulin delivery. Schade DS; Eaton RP; Spencer W Diabetes Care; 1980; 3(1):9-14. PubMed ID: 6996975 [TBL] [Abstract][Full Text] [Related]
49. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes. Nankervis A; Proietto J; Aitken P; Harewood M; Alford F Diabetologia; 1982 Oct; 23(4):320-5. PubMed ID: 6754516 [TBL] [Abstract][Full Text] [Related]
50. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Berrish TS; Hetherington CS; Alberti KG; Walker M Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492 [TBL] [Abstract][Full Text] [Related]
51. Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation. Båvenholm PN; Kuhl J; Pigon J; Saha AK; Ruderman NB; Efendic S J Clin Endocrinol Metab; 2003 Jan; 88(1):82-7. PubMed ID: 12519834 [TBL] [Abstract][Full Text] [Related]
52. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels. Schmitz O Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853 [TBL] [Abstract][Full Text] [Related]
53. Comparison of porcine and semisynthetic human insulins using euglycemic clamp-derived glucose-insulin dose-response curves in insulin-dependent diabetes. Staten M; Worcester B; Szekeres A; Waldeck N; Ascher M; Walsh KM; Rizza R; Gerich J; Charles MA Metabolism; 1984 Feb; 33(2):132-5. PubMed ID: 6363874 [TBL] [Abstract][Full Text] [Related]
54. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
55. The course and determinants of insulin action in type 1 (insulin-dependent) diabetes mellitus. Nijs HG; Radder JK; Frölich M; Krans HM Diabetologia; 1989 Jan; 32(1):20-7. PubMed ID: 2651185 [TBL] [Abstract][Full Text] [Related]
56. Insulin insensitivity in offspring of parents with type 2 diabetes mellitus. Ho LT; Chang ZY; Wang JT; Li SH; Liu YF; Chen YD; Reaven GM Diabet Med; 1990 Jan; 7(1):31-4. PubMed ID: 1967567 [TBL] [Abstract][Full Text] [Related]
57. Changes in insulin resistance with long-term insulin therapy. Sharp PS; Mohan V; Vitelli F; Maneschi F; Kohner EM Diabetes Care; 1987; 10(1):56-61. PubMed ID: 3552514 [TBL] [Abstract][Full Text] [Related]
58. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039 [TBL] [Abstract][Full Text] [Related]
59. Three months energy restricted diet does not reduce peripheral insulin resistance in newly diagnosed non insulin dependent diabetics. Walshe K; Andrews WJ; Sheridan B; Woods R; Hadden DR Horm Metab Res; 1987 May; 19(5):197-200. PubMed ID: 3556373 [TBL] [Abstract][Full Text] [Related]
60. Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin). Mimura A; Kageyama S; Maruyama M; Ikeda Y; Isogai Y Horm Metab Res; 1994 Apr; 26(4):184-7. PubMed ID: 8082872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]